SCHEMBL20660787

SCHEMBL20660787

COC(=O)c1ccnn1CC(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ F2 P00734 1/20 0.46
▸ PLAU P00749 1/20 0.46
▸ KLKB1 P03952 1/20 0.46
▸ ELANE P08246 1/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ RAB9A P51151 4/20 0.39
▸ NPC1 O15118 3/20 0.39
▸ KMT2A Q03164 5/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ ALDH1A1 P00352 3/20 0.38
▸ MAPT P10636 2/20 0.38
▸ HPGD P15428 1/20 0.38
▸ NPSR1 Q6W5P4 1/20 0.38
▸ MITF O75030 1/20 0.37
▸ S1PR4 O95977 1/20 0.37
▸ S1PR1 P21453 1/20 0.37
▸ HTT P42858 1/20 0.36
▸ FLT1 P17948 1/20 0.36
▸ KDR P35968 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20156357 0.84 MAPK1 (0.44) F2PLAUKLKB1ELANEL3MBTL1
SCHEMBL22125716 0.84 KDM4E (0.41) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL24937400 0.83 L3MBTL1 (0.56) F2PLAUKLKB1ELANEL3MBTL1
SCHEMBL7056151 0.83 F2 (0.48) F2PLAUKLKB1ELANEL3MBTL1
SCHEMBL7056155 0.83 F2 (0.48) F2PLAUKLKB1ELANEL3MBTL1
SCHEMBL29328550 0.81 F2 (0.48) F2PLAUKLKB1ELANERAB9A
SCHEMBL31460083 0.81 F2 (0.47) F2PLAUKLKB1ELANEL3MBTL1
SCHEMBL17962534 0.81 MAPK1 (0.42) L3MBTL1RAB9ANPC1KMT2AMEN1
SCHEMBL30829495 0.80 F2 (0.46) F2PLAUKLKB1ELANEL3MBTL1
SCHEMBL24875516 0.79 F2 (0.44) F2PLAUKLKB1ELANEL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 — — US disclosed
US-11548867-B2 Amido compounds as AhR modulators IDEA YA BIOSCIENCES, INC. (US) 2023-01-10 — — US disclosed
US-20220340875-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. 2022-10-27 — — US disclosed
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2021-04-22 — — US disclosed
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. 2021-04-22 — — US disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 — — WO disclosed
WO-2020018848-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS IDEAYA BIOSCIENCES, INC. (US) 2020-01-23 — — WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 — — WO disclosed
WO-2019018562-A1 AMIDO COMPOUNDS AS AhR MODULATORS IDEAYA BIOSCIENCES, INC. (US) 2019-01-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220340875-A1 METHODS OF CULTURING AND/OR EXPANDING STEM CELLS AND/OR LINEAGE COMMITTED PROGENITOR CELLS USING AMIDO COMPOUNDS AHR, MCL1, ARNT F2 2276/4885PLAU 4284/4885KLKB1 3122/4885
US-20210115016-A1 AMIDO COMPOUNDS AS AhR MODULATORS AHR, ARNT, RXRB F2 1306/4885PLAU 4828/4885KLKB1 4166/4885
US-11548867-B2 Amido compounds as AhR modulators AHR, ARNT, RXRB F2 1306/4885PLAU 4828/4885KLKB1 4166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback